Sr. Manager of Patient Engagement, Oncology | Young Breast Cancer Survivor and Patient Experience Advocate | Healthcare & Biotechnology Content Marketing and Social Media Strategy
When Danielle’s breast cancer molecular recurrence was detected by Natera's Signatera test, she and her doctor had incentive to act quickly. “I caught it at the molecular level and was able to intervene with treatment,” Danielle shared. Now, she’s celebrating consecutive negative Signatera tests! 💕 Hear more about her journey and how Signatera testing can help breast cancer survivors monitor for recurrences: https://ow.ly/bPsJ50TBC3S #BreastCancer #Natera